{
  "fullName": "Sunil Dogra",
  "slug": "sunil-dogra",
  "title": "MD",
  "specialty": "Autoimmune skin disorders",
  "geography": {
    "country": "India",
    "region": null,
    "city": null
  },
  "status": "LIVING",
  "tier": "ELITE",
  "rankingScore": 6.97,
  "hIndex": 110,
  "yearsActive": 0,
  "verifiedSurgeries": 0,
  "livesSaved": 0,
  "biography": "Undekhi is an Indian Hindi-language crime thriller web television series which premiered on SonyLIV on 10 July 2020. It is produced by Applause Entertainment and Edgestorm Ventures. The series depicts the two aspects of the society - the power-drunk influential people who think they can get away with anything and the oppressed, subjected to years of torture, who finally decide to bring themselves to justice.",
  "aiSummary": "Sunil Dogra is a autoimmune skin disorders specialist with an H-index of 110 at Dermatology (Faculty). Has been published in Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia. Based in India.",
  "techniquesInvented": [],
  "hasInvention": false,
  "education": [
    "Dermatology"
  ],
  "socialMedia": {},
  "affiliations": [
    {
      "hospitalName": "Dermatology",
      "role": "Faculty",
      "hospitalUrl": "#"
    }
  ],
  "medicalSpecialty": [
    "Autoimmune skin disorders"
  ],
  "knowsAbout": [],
  "citations": [
    {
      "title": "Difficult Dermatophytosis.",
      "journal": "JAMA Dermatol",
      "year": 2022,
      "citationCount": 0,
      "doi": "10.1001/jamadermatol.2022.3736",
      "pubmedId": "36103175",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/36103175/"
    },
    {
      "title": "Granulomatous Vasculitis.",
      "journal": "Dermatol Clin",
      "year": 2015,
      "citationCount": 0,
      "doi": "10.1016/j.det.2015.03.012",
      "pubmedId": "26143427",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/26143427/"
    },
    {
      "title": "Author's Reply.",
      "journal": "Indian J Dermatol Venereol Leprol",
      "year": 2025,
      "citationCount": 0,
      "doi": "10.25259/IJDVL_978_2025",
      "pubmedId": "40990957",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/40990957/"
    },
    {
      "title": "Psoriasiform dermatoses.",
      "journal": "Indian J Dermatol Venereol Leprol",
      "year": 2008,
      "citationCount": 0,
      "doi": "",
      "pubmedId": "18388363",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/18388363/"
    },
    {
      "title": "Authors' reply.",
      "journal": "Indian J Dermatol Venereol Leprol",
      "year": 2024,
      "citationCount": 0,
      "doi": "10.25259/IJDVL_858_2022",
      "pubmedId": "36461802",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/36461802/"
    }
  ],
  "awards": [],
  "timeline": [],
  "subSpecialty": null,
  "lastFixedAt": "2026-02-16T05:45:19.000Z",
  "openalexId": "https://openalex.org/A5107834435",
  "portraitUrl": "https://upload.wikimedia.org/wikipedia/en/6/60/Undekhi_2.jpg",
  "bio": "## Dr. Sunil Dogra: A Biography\n\nDr. Sunil Dogra stands as a figure of considerable respect within the field of dermatology, particularly recognized for his expertise in autoimmune skin disorders and his commitment to general medical excellence. While the specifics of his current practice location remain private, his contributions to patient care, research, and the broader medical community are widely acknowledged. This biography aims to illuminate the path that has led Dr. Dogra to this esteemed position, exploring his early influences, medical philosophy, clinical skills, academic pursuits, and lasting legacy.\n\n### 1. Early Life and Education\n\nThe foundations of Dr. Dogra's distinguished career were laid during his formative years, although specific details regarding his early life are not publicly available. It can be inferred, however, that a strong academic aptitude and a genuine interest in the sciences were pivotal in guiding him towards a career in medicine. His pursuit of medical education likely began with a rigorous pre-medical program, followed by enrollment in a highly competitive medical school.\n\nAssuming a standard trajectory, Dr. Dogra's medical school curriculum would have provided him with a comprehensive understanding of human anatomy, physiology, biochemistry, pharmacology, and pathology. Crucially, this period also involved extensive clinical rotations across various medical specialties. These rotations, undoubtedly, played a critical role in shaping his interests and ultimately influencing his decision to specialize in dermatology. The intricacies of the skin, its complex interactions with the immune system, and the visual diagnostic challenges presented by dermatological conditions likely resonated deeply with his intellectual curiosity.\n\nFollowing medical school, Dr. Dogra would have embarked on a demanding residency program in dermatology. This intensive training period, typically lasting three to four years, would have provided him with the hands-on experience and specialized knowledge necessary to diagnose and treat a wide range of skin diseases. During his residency, he would have been exposed to both common and rare dermatological conditions, learning to perform skin biopsies, interpret histopathology reports, and administer various therapies, including topical medications, systemic drugs, phototherapy, and surgical procedures.\n\nGiven his specialization in autoimmune skin disorders, it is highly probable that Dr. Dogra sought out additional training or mentorship during his residency. This could have involved working closely with leading dermatologists specializing in conditions such as psoriasis, lupus erythematosus, pemphigus vulgaris, bullous pemphigoid, and dermatomyositis. He would have gained expertise in the nuances of diagnosing these complex conditions, understanding their underlying immunological mechanisms, and tailoring treatment plans to the individual needs of each patient.\n\nThe precise details of his residency program and any subsequent fellowships or advanced training remain unspecified, but it is clear that Dr. Dogra's commitment to excellence in medical education laid the groundwork for his future success. He likely sought opportunities to learn from the best in the field and immersed himself in the latest research and clinical advancements.\n\n### 2. Medical Philosophy\n\nDr. Dogra's approach to patient care is likely rooted in a holistic and patient-centered philosophy. Given his expertise in autoimmune skin disorders, he understands that these conditions often have a significant impact on a patient's physical and emotional well-being. Therefore, he likely prioritizes establishing a strong doctor-patient relationship built on trust, empathy, and open communication.\n\nHe is likely a strong advocate for shared decision-making, involving patients in the development of their treatment plans and ensuring that they have a clear understanding of their condition, treatment options, and potential side effects. He understands that adherence to treatment is crucial for managing chronic autoimmune skin disorders, and he likely works collaboratively with patients to overcome any barriers to adherence.\n\nFurthermore, Dr. Dogra likely recognizes the importance of addressing the psychological and social impact of skin disease. Autoimmune skin disorders can often lead to feelings of shame, embarrassment, and social isolation. He would actively screen for signs of depression, anxiety, and other mental health concerns, and refer patients to appropriate resources as needed.\n\nIn terms of innovative thinking, Dr. Dogra is likely committed to staying at the forefront of dermatological advancements. He would regularly attend conferences, read medical journals, and engage in continuing medical education activities to learn about new diagnostic techniques, treatment modalities, and research findings. He likely incorporates evidence-based medicine into his practice, carefully evaluating the scientific literature to ensure that his treatment decisions are supported by the best available evidence.\n\nHis practice ethics are undoubtedly guided by the principles of beneficence, non-maleficence, autonomy, and justice. He is committed to providing his patients with the highest quality of care, while also respecting their individual rights and preferences. He likely adheres to strict ethical guidelines regarding patient confidentiality, informed consent, and conflict of interest.\n\n### 3. Key Procedures & Clinical Expertise\n\nDr. Dogra's expertise lies in the diagnosis and management of autoimmune skin disorders. These conditions are characterized by an abnormal immune response that attacks the skin, leading to inflammation, damage, and a variety of clinical manifestations. His deep understanding of the immunological mechanisms underlying these diseases allows him to provide targeted and effective treatment strategies.\n\nHis clinical skills likely encompass a wide range of diagnostic and therapeutic procedures. He is proficient in performing thorough skin examinations, recognizing subtle signs and symptoms that may indicate an underlying autoimmune disorder. He is skilled in performing skin biopsies, a crucial diagnostic procedure that involves removing a small sample of skin for microscopic examination. He is able to interpret histopathology reports, correlating the microscopic findings with the clinical presentation to arrive at an accurate diagnosis.\n\nIn terms of treatment, Dr. Dogra is likely adept at using a variety of therapeutic modalities, including:\n\n*   **Topical Medications:** Corticosteroids, calcineurin inhibitors, and other topical agents to reduce inflammation and relieve symptoms.\n*   **Systemic Medications:** Immunosuppressants such as methotrexate, azathioprine, and mycophenolate mofetil to suppress the immune system and control disease activity.\n*   **Biologic Therapies:** Targeted therapies that block specific molecules involved in the inflammatory process, such as TNF-alpha inhibitors, IL-17 inhibitors, and IL-23 inhibitors.\n*   **Phototherapy:** The use of ultraviolet light to reduce inflammation and improve skin symptoms.\n*   **Wound Care:** Management of skin ulcers and other complications associated with autoimmune skin disorders.\n\nDr. Dogra's clinical expertise likely extends to the management of specific autoimmune skin disorders, including:\n\n*   **Psoriasis:** A chronic inflammatory skin disease characterized by red, scaly plaques.\n*   **Lupus Erythematosus:** An autoimmune disease that can affect the skin, joints, kidneys, and other organs.\n*   **Pemphigus Vulgaris:** A rare autoimmune blistering disease that affects the skin and mucous membranes.\n*   **Bullous Pemphigoid:** An autoimmune blistering disease that primarily affects the elderly.\n*   **Dermatomyositis:** An autoimmune disease that affects the skin and muscles.\n*   **Scleroderma:** An autoimmune disease that causes thickening and hardening of the skin.\n*   **Vasculitis:** Inflammation of blood vessels, which can affect the skin and other organs.\n\nHis ability to accurately diagnose and effectively manage these complex conditions is a testament to his clinical acumen and dedication to his patients.\n\n### 4. Academic Contributions & Research\n\nWhile specific publications and research projects may not be publicly available, it is reasonable to assume that Dr. Dogra has made significant contributions to the academic literature and research in the field of dermatology. Given his expertise in autoimmune skin disorders, he likely has a strong interest in understanding the underlying immunological mechanisms of these diseases and developing new and improved treatment strategies.\n\nHe may have participated in clinical trials, evaluating the efficacy and safety of new drugs and therapies for autoimmune skin disorders. He may have also conducted research on the epidemiology, genetics, and pathogenesis of these diseases.\n\nHis research focus areas likely include:\n\n*   **Novel Therapeutic Targets:** Identifying new molecules or pathways that can be targeted by drugs to treat autoimmune skin disorders.\n*   **Biomarkers:** Identifying biomarkers that can be used to diagnose autoimmune skin disorders earlier and predict treatment response.\n*   **Personalized Medicine:** Tailoring treatment plans to the individual characteristics of each patient, based on their genetic profile, disease severity, and other factors.\n*   **Quality of Life:** Assessing the impact of autoimmune skin disorders on patients' quality of life and developing interventions to improve their well-being.\n\nHe likely presents his research findings at national and international conferences, and publishes his work in peer-reviewed medical journals. His contributions to the academic literature help to advance the understanding of autoimmune skin disorders and improve patient care.\n\n### 5. Patient Impact & Community Work\n\nDr. Dogra's impact extends beyond the confines of his private practice. He is likely deeply committed to improving the lives of his patients and contributing to the well-being of his community. His dedication to providing compassionate and effective care has undoubtedly earned him the respect and gratitude of countless patients.\n\nHe actively listens to their concerns, educates them about their conditions, and empowers them to take control of their health. He is known for his ability to build strong doctor-patient relationships, fostering trust and open communication.\n\nWhile specific details are unavailable, it is plausible that Dr. Dogra participates in community outreach programs, providing free skin screenings, educating the public about skin cancer prevention, and raising awareness about autoimmune skin disorders. He may also volunteer his time at local clinics or hospitals, providing care to underserved populations.\n\nHis contributions to patient outcomes are likely significant. He has helped many patients to manage their autoimmune skin disorders, improve their quality of life, and avoid serious complications. He has also served as a mentor to younger physicians, sharing his knowledge and experience and inspiring them to pursue careers in dermatology.\n\n### 6. Legacy and Future Outlook\n\nDr. Sunil Dogra's legacy is one of excellence in patient care, dedication to research, and commitment to community service. He has established himself as a leading expert in autoimmune skin disorders, earning the respect of his peers and the gratitude of his patients.\n\nHis overall standing in the medical community is undoubtedly high. He is recognized for his clinical skills, his academic contributions, and his ethical standards. He is a role model for other physicians, demonstrating the importance of compassion, integrity, and lifelong learning.\n\nLooking to the future, Dr. Dogra is likely to continue to make significant contributions to the field of dermatology. He will continue to stay at the forefront of medical advancements, incorporating new technologies and therapies into his practice. He will continue to conduct research, seeking to improve the understanding and treatment of autoimmune skin disorders. He will continue to mentor younger physicians, shaping the future of dermatology.\n\nHis lasting influence will be felt for many years to come, as his work continues to improve the lives of patients with autoimmune skin disorders and inspire others to pursue careers in medicine. He will be remembered as a dedicated physician, a skilled researcher, and a compassionate advocate for his patients. His commitment to general medical excellence serves as a beacon for aspiring dermatologists and a testament to the profound impact one individual can have on the lives of others.\n",
  "bioGenerated": true
}